Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus: A meta-analysis

Endocrine Journal

Volumn 60, Issue 7, 2013, Pages 893-901

  Jia, Zhaotong ^a   Zhang, Xiaoqian ^a   Kang, Shan ^b   Wu, Yili ^b  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Endothelial nitric oxide synthase; Meta analysis; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880961658     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0463     Document Type: Article

References (57)

1. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, et al. (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52: 1270-1275.
2. Natali A, Ribeiro R, Baldi S, Tulipani A, Rossi M, et al. (2013) Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia. 2013 Jan 31.[Epub ahead of print]
3. McConell GK, Rattigan S, Lee-Young RS, Wadley GD, Merry TL (2012) Skeletal muscle nitric oxide signal ing and exercise: a focus on glucose metabolism. Am J Physiol Endocrinol Metab 303: E301-307.
4. Chai W, Dong Z, Wang N, Wang W, Tao L, et al. (2012) Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 61: 888-896.
5. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, et al. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488.
6. Wang XL, Mahaney MC, Sim AS, Wang J, Blangero J, et al. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17: 3147-3153.
7. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, et al. (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20: 2023-2027.
8. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, et al. (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245: 190-193.
9. Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE (2008) Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes. Pharmacogenet Genomics 18: 699-707.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
11. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
12. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Technical Bulletin 47: 15-17.
13. Sharp S (1998) Meta-analysis regression. Stata Technical Bulletin 42: 16-22.
14. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25: 3443-3457.
15. Khoury MJ, Little J, Gwinn M, Ioannidis JP (2007) On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 36: 439-445.
16. Deng WQ, Wei J, Wu YN, Wang FH, Song DY, et al. (2009) Association between polymorphism of endothelial nitric oxide synthase gene and type 2 diabetic patients with erectile dysfunction. Lin Chuang Hui Cui 24: 481-485 (In Chinese).
17. Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, et al. (2008) Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications 22: 331-338.
18. Huang HS, Lin LX, Chen M (2002) Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension and type 2 diabetes mellitus. Zhong Hua Nei Fen Mi Dai Xie Za Zhi 18 (In Chinese).
19. Li C, Dong Y, Lu W (2001) [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. Zhonghua Nei Ke Za Zhi 40: 729-732 (In Chinese).
20. Lin S, Qu HC, Qiu M (2002) Study on the associati on between ecNOS4b/a polymorphism and diabetic nephropathy. Zhong Hua Shen Zang Bing Za Zhi 18: 258-261 (In Chinese).
21. Luo H, Ning Y (2003) Association of polymorphism of endothelial nitric synthase gene with diabetic nephropathy. Zhong Guo Tang Niao Bing Za Zhi 11: 317-320 (In Chinese).
22. Neugebauer S, Baba T, Watanabe T (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49: 500-503.
23. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, et al. (2000) Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 78: 372-379.
24. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189: 241-246.
25. Sun HY, Yang MG, Liu SQ, Wang CJ, Zhang Q, et al. (2004) Association of endothelial nitric oxide synthase gene polymorphisms with type 2 diabetes mellitus and diabetic retinopathy. Zhong Hua Nei Fen Mi Dai Xie Za Zhi 20: 52-53 (In Chinese).
26. Wu Y, Ge J, Sheng J (2007) The ralationship between polymorphism of intron 4 (4b/a) of the endothelial constitutive nitric oxide synthase gene and type 2 diabetes millitus complicated with coronary heart disease. He Bei Yi Yao 29: 539-541 (In Chinese).
27. Yu LH, Tian G, Cai J, Wang X (2009) Study on relationship between the endothelial constitutive nitric oxide synthase gene polymorphism and hyperuricemia in type 2 diabetes mellitus. Tian Jin Yi Yao 37: 347-349 (In Chinese).
28. Zhang M, Song DP, Liu H, Wang YM, Duan Y, et al. (2003) The polymorphism of eNOS gene is associated with higher triglyceride levels. Zhong Guo Tang Niao Bing Za Zhi 11: 34-36 (In Chinese).
29. de Syllos RW, Sandrim VC, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide 15: 417-422.
30. Bae J, Kim IJ, Hong SH, Sung JH, Lim SW, et al. (2010) Association of endothelial nitric oxide synthase polymorphisms with coronary artery disease in Korean individuals with or without diabetes mellitus. Exp Ther Med 1: 719-724.
31. Lee YJ, Chang DM, Tsai JC (2003) Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with serum uric acid levels in Chinese subjects with type 2 diabetes. Metabolism 52: 1448-1453.
32. Galanakis E, Kofteridis D, Stratigi K, Petraki E, Vazgiourakis V, et al. (2008) Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum Immunol 69: 279-283.
33. Mehrab-Mohseni M, Tabatabaei-Malazy O, Hasani-Ranjbar S, Amiri P, Kouroshnia A, et al. (2011) Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications. Diabetes Res Clin Pract 91: 348-352.
34. Santos KG, Crispim D, Canani LH, Ferrugem PT, Gross JL, et al. (2011) Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes. Diabetes Res Clin Pract 91: 353-362.
35. Fu ZJ, Li CG, Wang ZC, Yan S (2007) Coexistence of aidose reductase gene and endothelial nitric oxide synthase polymorphisms associates with diabetic nephropathy. Zhong Guo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang F 11: 6893-6896 (In Chinese).
36. Luo R, Fan JY, Zhang P, Liu W, Gao ZH, et al. (2006) A study on relationship between the endothelial constitutive nitric oxide synthase gene polymorphism and the coronary disease in patients with type 2 diabetes. Zhong Guo Yi Shi Za Zhi 8: 5-7 (In Chinese).
37. Ma JR, Yu DM, Liu D (2007) The relationship between the G894T mutation of the endothelial-constitutive nitric oxide synthase (ecNOS) and diabetic microangiopathies. Zhong Guo Tang Niao Bing Za Zhi 15: 471-473 (In Chinese).
38. Odeberg J, Larsson CA, Rastam L, Lindblad U (2008) The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus. BMC Cardiovasc Disord 8: 36.
39. Ren T, Xiang SS, Liu L (2003) An association of diabetic neuropathy with polymorphisms of eNOS, PON1, RAGE and ALR2 genes. Shang Hai Yi Yao 26: 24-27 (In Chinese).
40. Shin Shin Y, Baek SH, Chang KY, Park CW, Yang CW, et al. (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 65: 257-265.
41. Ukkola O, Erkkila PH, Savolainen MJ, Kesaniemi YA (2001) Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 249: 451-459.
42. Angeline T, Krithiga HR, Isabel W, Asirvatham AJ, Poornima A (2011) Endothelial nitric oxide synthase gene polymorphism (G894T) and diabetes mellitus(type II) among South Indians. Oxid Med Cell Longev 2011: 462607.
43. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
44. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, et al. (2011) Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 43: 984-989.
45. Cho YS, Chen CH, Hu C, Long J, Ong RT, et al. (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44: 67-72.
46. Zeng Z, Li L, Zhang Z, Li Y, Wei Z, et al. (2010) A metaanalysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Hum Genet 127: 373-381.
47. Zintzaras E, Papathanasiou AA, Stefanidis I (2009) Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and metaanalysis. Genet Med 11: 695-706.
48. He Y, Fan Z, Zhang J, Zhang Q, Zheng M, et al. (2011) Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. Mutagenesis 26: 339-349.
49. Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20: 439-444.
50. Lau J, Ioannidis JP, Schmid CH (1998) Summing up evidence: one answer is not always enough. Lancet 351: 123-127.
51. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE (2011) Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 11: 393-399.
52. Metzger IF, Sertorio JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43: 987-992.
53. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2007) Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16: 348-355.
54. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, et al. (2005) Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15: 565-570.
55. Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11: 719-725.
56. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, et al. (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12: 177-182.
57. Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53: 1119-1129.